Dr. Agarwal's Health Care Ltd. Share Price

Overview

Dr. Agarwal's Health Care Ltd. share price is currently ₹474.66, up by ₹14.16 (3.07%) from its previous closing price of ₹460.50. The share price has declined -6.87% over the past month and declined -3.52% over the past year. The stock's 52-week low and high are ₹393.44 and ₹565.34, respectively. Dr. Agarwal's Health Care Ltd. has a market capitalisation of ₹ 15,420.00 Cr. The share price was last updated on 09 Oct 2026, 03:56 PM IST.

Dr. Agarwal's Health Care Ltd.
Dr. Agarwal's Health Care Ltd.
AGARWALEYE
 ₹0.00
 ₹14.16
3.07%
Healthcare
 ₹0.00(%)1D

Updated: 09 Oct 2026, 03:56:30 pm IST

Market Data

Open Price

 ₹463.75

Prev. Close

 ₹460.50
 ₹455.84

Day Low

 ₹479.50

Day High

 ₹393.44

52 Week Low

 ₹565.34

52 Week High

HealthcareHospital & Healthcare Services
CategoryMid Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

101.21

Sector PE

43.59

PB Ratio

7.47

Sector PB

5.76

EPS

4.69

Dividend Yield

0.00

Today's Volume

245.662 K

5 Day Avg. Volume

229.790 K

PEG Ratio

1.71

Market Cap.

₹ 15,420.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Corporate Actions will be available shortly.

Mutual Fund Ownership

Mutual Fund Holder
Aug 26
Shares held
Sep 26
Shares held
Canara Robeco Conservative Hybrid Fund - Regular Plan - Growth31.80 k
48.30 k
(51.89%)
iSIF Equity Long-Short Fund - Regular Plan - Growth1.40 Lac
-
(100%)
Tata Multi Asset Allocation Fund - Regular Plan - Growth15.92 Lac
-
(100%)
Tata India Pharma & Healthcare Fund - Regular Plan - Growth2.15 Lac
-
(100%)
PGIM India Small Cap Fund - Regular Plan - Growth5.38 Lac
-
(100%)

About Dr. Agarwal's Health Care Ltd. 👋

Dr. Agarwal's Health Care Ltd is an India-based company, which operates as a health care institution. The Company is engaged in running, owning and managing eye care hospitals, optical, pharmacies, etc. and related services. It provides a comprehensive range of eye care services, including cataract, refractive and other surgeries; consultations, diagnoses and non-surgical treatments; and sells optical, contact lenses and accessories, and eye-care related pharmaceutical products. Its services include surgeries and consultations, diagnoses and non-surgical treatments. Its surgery services include cataract surgery, refractive surgery, and other surgery. Its consultations, diagnoses and non-surgical treatments offer doctor consultation services, diagnostic services for eye disorders along with non-surgical treatments, including retinal laser therapy and dry eye treatment. It provides a range of glasses, lenses, contact lenses and frames at its facilities.

Expert Opinions

Insights from SEBI-registered analysts · updated live

Explore all →
Unite Technologies Financial

Unite Technologies Financial

28 Jul • 9:12 PM · SEBI-Registered Analyst

Technical Analysis Dr. Agarwal's Health Care

The stock

AGARWALEYE
is trading in a sideways-to-positive trend after recovering from its March-April correction. Over the last few weeks it has been consolidating between ₹475 and ₹500 showing that buyers are gradually returning but a decisive breakout is still pending. The chart shows higher lows from the April bottom indicating improving momentum. However repeated rejection near the ₹500 zone suggests that sellers are still active at higher levels. A strong close above this resistance could trigger the next uptrend. The stock has immediate support around ₹475-480 where buyers have repeatedly stepped in. A break below this zone could push the price toward ₹450-455. On the upside ₹500 is the key resistance. If the stock closes above this level with strong volume it may move towards ₹520-540. The outlook remains cautiously bullish as long as the stock holds above ₹475. Existing investors can continue to hold while fresh buying is better considered only after a confirmed breakout above ₹500 with good trading volume. The recent price action indicates accumulation rather than distribution.

See More
Unite Technologies Financial

Unite Technologies Financial

16 Jun • 11:34 PM · SEBI-Registered Analyst

Technical Analysis Dr. Agarwals Health Care Ltd.

The stock

AGARWALEYE
is enjoyed a strong bullish rally from June to November making a peak near the 570–580 zone. Since late 2025 the stock has been in a corrective downtrend forming lower highs and lower lows. It recently tried to bounce back in May 2026 but faced rejection near 490–500 and is sliding down again. Immediate Support the critical support zone lies around 400 – 420. The stock sharply reversed from this level in April 2026 making it a vital demand zone. Immediate Resistance heavy resistance is visible around the 490 – 510 range. The stock needs a strong daily close above 510 to break the current bearish structure. For short-term buyers it is safer to wait for the stock to stabilize near its major demand zone of 400–420 or look for a decisive breakout above the 510 resistance level before taking fresh entries. Entering at the current price of 438.45 carries risk as the short-term structure shows ongoing selling pressure with a pattern of lower highs. Current holders should keep a close eye on the crucial 400 level as sustaining below it could trigger a deeper correction and weaken the stock further.

See More
Sumit Kadam

Sumit Kadam

27 May • 2:55 PM · SEBI-Registered Analyst

Pharma Stocks Back In Investor Focus 💊📈

Pharmaceutical sector stocks remained in strong focus today as defensive buying and healthcare demand optimism supported positive investor sentiment. Stocks like SUNPHARMA, DIVISLAB, and CIPLA witnessed active market participation during today’s trading session. The pharma sector works like a defensive shield for the stock market. During uncertain or volatile market conditions, investors often prefer healthcare and pharmaceutical companies because demand for medicines and healthcare services generally remains stable. One major reason behind today’s momentum was continued optimism around export demand, strong domestic healthcare growth, and stable earnings visibility in the pharmaceutical sector. Investors are also tracking US market opportunities, product launches, and improving healthcare awareness, which are supporting long-term sector sentiment. For investors, this situation highlights how defensive sectors can attract attention during changing market conditions. Pharma stocks often remain important because healthcare demand usually stays consistent regardless of economic cycles. Stocks like SUNPHARMA, DIVISLAB, CIPLA, and DRREDDY may remain active as investors continue monitoring export growth and healthcare sector trends closely. SUNPHARMA

SUNPHARMA
DIVISLAB
DIVISLAB
CIPLA
CIPLA
LUPIN
LUPIN
Defensive sectors often create stability and long-term investment opportunities during uncertain market phases. Investors should understand that pharmaceutical sector stocks are influenced by healthcare demand, export opportunities, product innovation, and defensive market sentiment.

See More
Sohrab Shaikh (SEBI RA)

Sohrab Shaikh (SEBI RA)

27 Mar • 10:39 PM · SEBI-Registered Analyst

High delivery stocks as on 27/03/26

Symbol Delivered Qty MAHSCOOTER 32586 AIIL 2163151 BRIGADE 1488552 SPLPETRO 429968 VGUARD 1337196 HEG 3592084 ASTRAZEN 40728 UNIONBANK 55638692 HAVELLS 4460462 ICICIGI 4168742 AGARWALEYE 506897 KIRLOSBROS 180960 NAUKRI 7784477

VGUARD

See More
Sohrab Shaikh (SEBI RA)

Sohrab Shaikh (SEBI RA)

17 Mar • 11:56 PM · SEBI-Registered Analyst

High delivery stocks as on 17/03/26

Symbol Delivered Qty KPIL 525032 SBFC 4714343 VTL 408577 MASTEK 115454 VMM 24965178 AGARWALEYE 149669 INDIAMART 301454 KFINTECH 611348 CHENNPETRO 1246509 ITI 1837946

KPIL

See More
Sohrab Shaikh (SEBI RA)

Sohrab Shaikh (SEBI RA)

15 Jan • 12:15 AM · SEBI-Registered Analyst

High delivery stocks as on 14/01/2026

Symbol Delivered Qty AAVAS 2301631 AGARWALEYE 1334028 GODIGIT 1675350 MMTC 8664970 INDIAMART 312611 EIHOTEL 688523 HEXT 1484610 POLYCAB 1041428 CRAFTSMAN 64902 MRPL 5450257 JWL 2961400 CLEAN 316100 UNIONBANK 21480427 SUNDARMFIN 94914 ICICIGI 1182349 INDUSINDBK 6899785 CCL 347130 CESC 2069013

GODIGIT

See More

Frequently Asked Questions

What is the share price of Dr. Agarwal's Health Care Ltd.?

What is the market cap of Dr. Agarwal's Health Care Ltd.?

Should I buy Dr. Agarwal's Health Care Ltd. stock now?

What is the 52 week high and low of Dr. Agarwal's Health Care Ltd.?

Is the Dr. Agarwal's Health Care Ltd. stock good to buy?

Is Dr. Agarwal's Health Care Ltd. a good buy for the long term?

Is Dr. Agarwal's Health Care Ltd. overvalued or undervalued?

What is the PE and PB ratio of Dr. Agarwal's Health Care Ltd.?

Start Now